Ozempic and other glucagon-like peptide-1 (GLP-1) agonists are a transformative new class of medicines for the treatment of ...

If you have type 2 diabetes, the organ makes insulin, but your body doesn't use it right. Each works differently based on how long they take ... you short- or rapid-acting insulin.

The next FDA Commissioner could solve two big problems with one powerful policy: encourage independent testing of both ...

Unawareness is more common in people who've had diabetes a long ... insulin shock, ask them to check their blood sugar. Help them get what they need to follow the 15/15 rule: eat 15 grams of fast ...

Share on Pinterest LeoPatrizi/Getty Images Semaglutide is the active ingredient ... as “Ozempic rebound,” although it happens with all brands of semaglutide. “The research is clear that ...

The accident occurred in his mid-20s and at the peak of his early acting career ... Eric Roberts attends GBK Brand Bar Pre-Oscar luxury lounge at Beverly Wilshire. Photo: Tiffany Rose (modified by ...

The FDA has approved Merilog, the first-ever rapid-acting insulin biosimilar for diabetes treatment that helps manage blood ...

Aventis's Merilog (insulin-aspart-szjj) as a biosimilar to Novolog (insulin aspart) for adults and pediatric patients with ...

Sanofi's Merilog wins FDA approval as the first rapid-acting insulin biosimilar to Novolog, offering a new option for diabetes management.

Merilog also marks the third insulin biosimilar approved in the United States, following two long-acting biosimilars approved in 2021 ... while around 59% of all individuals living with diabetes were ...

The rapid-acting insulin aspart biosimilar joins two prior long-acting insulin biosimilar products approved in 2021. Biosimilars are highly similar to already approved products and have no ...

SILVER SPRING, Md., Feb. 14, 2025 /PRNewswire/ -- Today, the U.S. Food and Drug Administration approved Merilog (insulin-aspart-szjj) as biosimilar to Novolog (insulin aspart) for the improvement ...